---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Tue, Sep 16, 2014 at 7:17 AM
Subject: CDER New September 16, 2014
To: iammejtm@gmail.com
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Tue, Sep 16, 2014 at 7:17 AM
Subject: CDER New September 16, 2014
To: iammejtm@gmail.com
What's New on the FDA Drugs Site
September 15, 2014
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- National Drug Code Directory
- Pediatric Medical, Statistical, and Clinical Pharmacology BPCA and PREA Reviews (updated)
- Public Notification: Japan Hokkaido Slimming Weight Loss Pills Contain Hidden Drug Ingredients
- Public Notification: Mezo Contains Hidden Drug Ingredient
- Public Notification: LX1 Contains Hidden Drug Ingredient
- Public Notification: Best Line Suplemento Alimenticio Capsules Contains Hidden Drug Ingredient
New and Generic Drug Approvals
September 12, 2014
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
---|---|---|---|---|
Advil Liqui-Gels | ibuprofen | Capsule;Oral | Pfizer | Manufacturing Change or Addition |
Advil Migraine Liqui-Gels | ibuprofen | Capsule;Oral | Pfizer | Manufacturing Change or Addition |
Afinitor | everolimus | Tablet;Oral | Novartis | Manufacturing Change or Addition |
Allegra Allergy | fexofenadine hydrochloride | Tablet;Oral | Sanofi Aventis Us | Labeling Revision |
Allegra Hives | fexofenadine hydrochloride | Tablet;Oral | Sanofi Aventis Us | Labeling Revision |
Amlodipine and Valsartan | amlodipine;valsartan | Tablet;Oral | Torrent Pharms Ltd | Tentative Approval |
An-Sulfur Colloid | technetium tc-99m sulfur colloid kit | Solution;Injection, Oral | Pharmalucence | Manufacturing Change or Addition |
Children's Allegra Allergy | fexofenadine hydrochloride | Tablet;Oral | Sanofi Aventis Us | Labeling Revision |
Children's Allegra Hives | fexofenadine hydrochloride | Tablet;Oral | Sanofi Aventis Us | Labeling Revision |
Clindamycin Phosphate and Benzoyl Peroxide | benzoyl peroxide; clindamycin phosphate | Gel;Topical | Mylan Pharms Inc | Manufacturing Change or Addition |
Daptomycin | daptomycin | Injectable;Injection | Hospira Inc | Approval |
Emtricitabine;Tenofovir Disoproxil Fumarate;Nevirapine | emtricitabine;tenofovir disoproxil fumarate;nevirapine | Tablet;Oral | Mylan Labs Ltd | Tentative Approval |
Forteo | teriparatide recombinant human | Injectable;Subcutaneous | Lilly | Manufacturing Change or Addition |
Glycine 1.5% In Plastic Container | glycine | Solution;Irrigation | B Braun | Manufacturing Change or Addition |
Humalog | insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Kwikpen | insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Mix 50/50 | insulin lispro protamine recombinant; insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Mix 50/50 Kwikpen | insulin lispro protamine recombinant; insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Mix 50/50 Pen | insulin lispro protamine recombinant; insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Mix 75/25 | insulin lispro protamine recombinant; insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Mix 75/25 Kwikpen | insulin lispro protamine recombinant; insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Mix 75/25 Pen | insulin lispro protamine recombinant; insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humalog Pen | insulin lispro recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humatrope | somatropin recombinant | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humulin 70/30 | insulin recombinant human; insulin susp isophane recombinant human | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humulin 70/30 Pen | insulin recombinant human; insulin susp isophane recombinant human | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Humulin N | insulin susp isophane recombinant human | Injectable;Injection | Lilly | Manufacturing Change or Addition |
Mycophenolate Mofetil | mycophenolate mofetil | Capsule;Oral | Roxane | Manufacturing Change or Addition |
Mycophenolate Mofetil | mycophenolate mofetil | Tablet;Oral | Roxane | Manufacturing Change or Addition |
Naprelan | naproxen sodium | Tablet, Extended Release;Oral | Almatica Pharma Inc | Manufacturing Change or Addition |
Pomalyst | pomalidomide | Capsule;Oral | Celgene | Labeling Revision |
Revlimid | lenalidomide | Capsule;Oral | Celgene | Labeling Revision |
Thalomid | thalidomide | Capsule;Oral | Celgene | Supplement |
Vibra-Tabs | doxycycline hyclate | Tablet;Oral | Pfizer | Labeling Revision |
Vibramycin | doxycycline | For Suspension;Oral | Pfizer | Labeling Revision |
Vibramycin | doxycycline hyclate | Capsule;Oral | Pfizer | Labeling Revision |
Vibramycin | doxycycline calcium | Suspension;Oral | Pfizer | Labeling Revision |
Zoloft | sertraline hydrochloride | Tablet;Oral | Pfizer | Labeling Revision |
Zoloft | sertraline hydrochloride | Concentrate;Oral | Pfizer | Labeling Revision |
This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |
Jeremy Tobias Matthews
No comments:
Post a Comment